INOVIQ Ltd (ASX:IIQ)
Australia flag Australia · Delayed Price · Currency is AUD
0.3950
+0.0100 (2.60%)
Aug 1, 2025, 4:10 PM AEST

INOVIQ Company Description

INOVIQ Ltd engages in the developing and commercializing of diagnostic and exosome‐based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States.

The company offers hTERT test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET, an EV isolation tool for biomarker discovery and diagnostic development.

Its cancer diagnostic pipeline includes internal and partnered diagnostic tests for improved screening, diagnosis, treatment selection and monitoring of cancer and other diseases.

The company was formerly known as BARD1 Life Sciences Limited and changed its name to INOVIQ Ltd in December 2021.

INOVIQ Ltd was founded in 2016 and is headquartered in Notting Hill, Australia.

INOVIQ Ltd
CountryAustralia
Founded2016
IndustryDiagnostics & Research
SectorHealthcare
Employees15
CEOLeearne Hinch

Contact Details

Address:
23 Normanby Road
Notting Hill, 3168
Australia
Phone61 3 9548 7586
Websiteinoviq.com

Stock Details

Ticker SymbolIIQ
ExchangeAustralian Securities Exchange
Fiscal YearJuly - June
Reporting CurrencyAUD
ISIN NumberAU0000196149
SIC Code1040

Key Executives

NamePosition
Dr. Leearne Maree Hinch B.Sc., B.V.M.S., BSc., M.B.A., M.R.C.V.S.Chief Executive Officer
Mark Edwards BAcc, C.A., CAChief Financial Officer and Company Secretary
Dr. Gregory Edward Rice BSc (Hons), GradDipMgt, MHA, Ph.D.Chief Scientific Officer
Dr. Emma Ball B.Sc., M.B.A., Ph.D.Chief Commercial Officer